Skip to content
GLP-1 Scorecard
Menu
Graded #292

NativeMed

NativeMed, LLC (nativemed.net) is a Miami, FL-based cash-pay telehealth provider offering compounded semaglutide at promotional $149/mo (regular $299) and compounded tirzepatide at promotional $183/mo (regular $399), plus NAD+ and several non-weight-loss generics.

Visit NativeMedWe may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$149/mo (promotional rate, compounded)
Tirzepatide
$183/mo (promotional rate, compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Weigh NativeMed against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. Because NativeMed dispenses compounded medication, it’s worth understanding whether compounded semaglutide is legit and safe.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value74/100
Dose & formulation64/100
Clinical oversight55/100
Labs & monitoring53/100
Fulfillment67/100
Contract terms55/100

Strengths

  • LegitScript Certified (verifiable in the footer)
  • Promotional pricing shown publicly: $149/mo semaglutide, $183/mo tirzepatide
  • Online questionnaire intake, with a live visit added when state law requires it

Where it loses points

  • Pharmacy partners aren't named — described only as 'USA-based' or 'accredited' pharmacies
  • States served aren't listed publicly
  • Prices are promotional — confirm whether they hold past month one or rise to the $299/$399 regular rate
  • FDA issued NativeMed LLC dba NativeMed a warning letter in June 2026; the letter is public in FDA's warning-letter database

Bottom line — Grade C

Best for: Shoppers who want sub-$200 promotional compounded GLP-1 pricing.

Ranked #292 of 544 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

FDAWarning letter issued to NativeMed LLC dba NativeMed in June 2026. See the FDA warning-letter database.

Closest here

The rankings grading nearest NativeMed — the realistic shortlist.

The 21 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect NativeMed's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on NativeMed's site. Not medical advice; see our disclosure.

← Back to the scorecard